It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Semaglutide drugs, like Ozempic and Wegovy, have helped millions of Americans lose weight, reduce cravings and better manage ...

Consumers who take copies of the popular weight loss and diabetes drug tirzepatide will likely need to find a new source for these medications early next year. On Thursday, the Food and Drug ...